SUBSCRIBE TO OUR FREE NEWSLETTER
Daily news & progressive opinion—funded by the people, not the corporations—delivered straight to your inbox.
5
#000000
#FFFFFF
To donate by check, phone, or other method, see our More Ways to Give page.
Daily news & progressive opinion—funded by the people, not the corporations—delivered straight to your inbox.
MRSA attacks a human cell. The bacteria shown is the strain MRSA 252, a leading cause of hospital-associated infections. (Image: Rocky Mountain Laboratories/NIAID/NIH)
A new plan for tackling the growing threat of antibiotic-resistant microbes, or so-called superbugs, addresses the unnecessary use of antibiotics and includes a call on Big Pharma to "play or pay" to help bring successful treatments to the market.
The report, commissioned by British Prime Minister David Cameron, was led by economist Jim O'Neill, who said that antibiotics were sometimes being handed out "like sweets."
"If we don't do something, we're heading towards a world where there will be no antibiotics available to treat people who need them," O'Neill told reporters at a London briefing.
Among the recommendations his report lays out, as noted by Press Association, are:
Explaining the "pay or play" proposal, Reuters reports that O'Neill's plan is for pharmaceutical companies to
be subject to a surcharge if they decide not to invest in research and development (R&D) to bring successful new antibiotic medicines to market.
For [those] who do decide to "play", he said, a reward of between $1 billion and $1.5 billion should be paid for any successful new antimicrobial medicine brought to market.
But that approach wouldn't be a panacea, said Dr. Grania Brigden, from the medical charity Medecins Sans Frontieres.
"The O'Neill report proposes considerable new funding to overcome the failures of pharmaceutical research and development, but the proposals do not necessarily ensure access to either existing tools or emerging new products," the BBC reports her as saying.
Addressing antibiotics being doled out in cases when it is not necessary, O'Neill called for "rapid diagnostics" to help determine if a patient is suffering from an infection that is, in fact, bacterial, as opposed to viral.
"II find it incredible that doctors must still prescribe antibiotics based only on their immediate assessment of a patient's symptoms, just like they used to when antibiotics first entered common use in the 1950s," O'Neill said in the report.
From the Guardian:
O'Neill said that stopping the over-use of antibiotics - also fed in vast quantities to animals for growth promotion as well as to treat disease, especially in the United States - may be even more important than incentivising the development of new drugs.
The point of antibiotic overuse in farm animals drew praise from the the Alliance to Save Our Antibiotics and the UK-based Soil Association.
"If we are to have a chance of tackling the antibiotic resistance crisis, we need to change the way we farm," said Peter Melchett, Policy Director at the Soil Association. "Global livestock antibiotic use is forecast to increase by 67% by 2030, due to the expected increasing intensification of global livestock systems. We know that organic and extensive systems use far fewer antibiotics than intensive systems."
The O'Neill report comes on the heels of an analysis by the U.S. Centers for Disease Control and Prevention (CDC), in collaboration with Pew Charitable Trusts and other public health and medical experts, showing that at least 30 percent of antibiotics prescribed in the United States are unnecessary, while the U.S. Food and Drug Administration previously found that 80 percent of all antibiotics used in the United States were for livestock.
Dear Common Dreams reader, The U.S. is on a fast track to authoritarianism like nothing I've ever seen. Meanwhile, corporate news outlets are utterly capitulating to Trump, twisting their coverage to avoid drawing his ire while lining up to stuff cash in his pockets. That's why I believe that Common Dreams is doing the best and most consequential reporting that we've ever done. Our small but mighty team is a progressive reporting powerhouse, covering the news every day that the corporate media never will. Our mission has always been simple: To inform. To inspire. And to ignite change for the common good. Now here's the key piece that I want all our readers to understand: None of this would be possible without your financial support. That's not just some fundraising cliche. It's the absolute and literal truth. We don't accept corporate advertising and never will. We don't have a paywall because we don't think people should be blocked from critical news based on their ability to pay. Everything we do is funded by the donations of readers like you. Will you donate now to help power the nonprofit, independent reporting of Common Dreams? Thank you for being a vital member of our community. Together, we can keep independent journalism alive when it’s needed most. - Craig Brown, Co-founder |
A new plan for tackling the growing threat of antibiotic-resistant microbes, or so-called superbugs, addresses the unnecessary use of antibiotics and includes a call on Big Pharma to "play or pay" to help bring successful treatments to the market.
The report, commissioned by British Prime Minister David Cameron, was led by economist Jim O'Neill, who said that antibiotics were sometimes being handed out "like sweets."
"If we don't do something, we're heading towards a world where there will be no antibiotics available to treat people who need them," O'Neill told reporters at a London briefing.
Among the recommendations his report lays out, as noted by Press Association, are:
Explaining the "pay or play" proposal, Reuters reports that O'Neill's plan is for pharmaceutical companies to
be subject to a surcharge if they decide not to invest in research and development (R&D) to bring successful new antibiotic medicines to market.
For [those] who do decide to "play", he said, a reward of between $1 billion and $1.5 billion should be paid for any successful new antimicrobial medicine brought to market.
But that approach wouldn't be a panacea, said Dr. Grania Brigden, from the medical charity Medecins Sans Frontieres.
"The O'Neill report proposes considerable new funding to overcome the failures of pharmaceutical research and development, but the proposals do not necessarily ensure access to either existing tools or emerging new products," the BBC reports her as saying.
Addressing antibiotics being doled out in cases when it is not necessary, O'Neill called for "rapid diagnostics" to help determine if a patient is suffering from an infection that is, in fact, bacterial, as opposed to viral.
"II find it incredible that doctors must still prescribe antibiotics based only on their immediate assessment of a patient's symptoms, just like they used to when antibiotics first entered common use in the 1950s," O'Neill said in the report.
From the Guardian:
O'Neill said that stopping the over-use of antibiotics - also fed in vast quantities to animals for growth promotion as well as to treat disease, especially in the United States - may be even more important than incentivising the development of new drugs.
The point of antibiotic overuse in farm animals drew praise from the the Alliance to Save Our Antibiotics and the UK-based Soil Association.
"If we are to have a chance of tackling the antibiotic resistance crisis, we need to change the way we farm," said Peter Melchett, Policy Director at the Soil Association. "Global livestock antibiotic use is forecast to increase by 67% by 2030, due to the expected increasing intensification of global livestock systems. We know that organic and extensive systems use far fewer antibiotics than intensive systems."
The O'Neill report comes on the heels of an analysis by the U.S. Centers for Disease Control and Prevention (CDC), in collaboration with Pew Charitable Trusts and other public health and medical experts, showing that at least 30 percent of antibiotics prescribed in the United States are unnecessary, while the U.S. Food and Drug Administration previously found that 80 percent of all antibiotics used in the United States were for livestock.
A new plan for tackling the growing threat of antibiotic-resistant microbes, or so-called superbugs, addresses the unnecessary use of antibiotics and includes a call on Big Pharma to "play or pay" to help bring successful treatments to the market.
The report, commissioned by British Prime Minister David Cameron, was led by economist Jim O'Neill, who said that antibiotics were sometimes being handed out "like sweets."
"If we don't do something, we're heading towards a world where there will be no antibiotics available to treat people who need them," O'Neill told reporters at a London briefing.
Among the recommendations his report lays out, as noted by Press Association, are:
Explaining the "pay or play" proposal, Reuters reports that O'Neill's plan is for pharmaceutical companies to
be subject to a surcharge if they decide not to invest in research and development (R&D) to bring successful new antibiotic medicines to market.
For [those] who do decide to "play", he said, a reward of between $1 billion and $1.5 billion should be paid for any successful new antimicrobial medicine brought to market.
But that approach wouldn't be a panacea, said Dr. Grania Brigden, from the medical charity Medecins Sans Frontieres.
"The O'Neill report proposes considerable new funding to overcome the failures of pharmaceutical research and development, but the proposals do not necessarily ensure access to either existing tools or emerging new products," the BBC reports her as saying.
Addressing antibiotics being doled out in cases when it is not necessary, O'Neill called for "rapid diagnostics" to help determine if a patient is suffering from an infection that is, in fact, bacterial, as opposed to viral.
"II find it incredible that doctors must still prescribe antibiotics based only on their immediate assessment of a patient's symptoms, just like they used to when antibiotics first entered common use in the 1950s," O'Neill said in the report.
From the Guardian:
O'Neill said that stopping the over-use of antibiotics - also fed in vast quantities to animals for growth promotion as well as to treat disease, especially in the United States - may be even more important than incentivising the development of new drugs.
The point of antibiotic overuse in farm animals drew praise from the the Alliance to Save Our Antibiotics and the UK-based Soil Association.
"If we are to have a chance of tackling the antibiotic resistance crisis, we need to change the way we farm," said Peter Melchett, Policy Director at the Soil Association. "Global livestock antibiotic use is forecast to increase by 67% by 2030, due to the expected increasing intensification of global livestock systems. We know that organic and extensive systems use far fewer antibiotics than intensive systems."
The O'Neill report comes on the heels of an analysis by the U.S. Centers for Disease Control and Prevention (CDC), in collaboration with Pew Charitable Trusts and other public health and medical experts, showing that at least 30 percent of antibiotics prescribed in the United States are unnecessary, while the U.S. Food and Drug Administration previously found that 80 percent of all antibiotics used in the United States were for livestock.